Giorgia Guglielmi
Targeting L-kynurenine metabolism could be a therapeutic strategy for managing Crohn’s disease.
The findings suggest that the composition of the gut microbiota in early life is not a key factor in obesity risk.
New research has now uncovered differences in the gut microbiota composition between people with the condition and those without.
Specific gut microbiota features correlate with better responses to immunotherapy in people with melanoma.
Including microbial load in microbiota studies can help researchers better understand how gut bacteria influence diseases, leading to more accurate diagnoses and effective treatments.
The findings highlight the importance of maintaining a healthy microbiota after EEN and suggest that personalized dietary approaches can help induce remission for children with Crohn’s disease.
The findings suggest that gut microbes and LPC are potential therapeutic targets for Alzheimer's disease.
Researchers have identified a new class of virus-like agents known as "obelisks" in oral and stool samples from hundred of people.
The findings suggest that 4-hydroxyindole could be a promising biomarker for diagnosing endometriosis.
The study identified a core microbiota signature that may serve as a health indicator and a therapeutic target.
